Aquasomes (ceramic nanoparticles) and microneedles offer promising alternatives to injections for delivering peptide drugs via oral and transdermal routes while maintaining stability and bioavailability.
150-1500 μmmicroneedle length range for painless transdermal peptide drug delivery
What the researchers found
Aquasomes enhance peptide stability through ceramic core-polyhydroxy oligomer coating for oral delivery. Microneedles (150-1500 μm) create transdermal pathways for peptide drugs. Both approaches address the key barriers of oral degradation and skin impermeability.
Why it matters
Patient compliance with injectable peptide drugs is a major clinical challenge. Alternative delivery routes could make peptide therapeutics more accessible and improve treatment adherence, especially for conditions requiring daily dosing.
The numbers in context
Aquasomes preserve peptide activity; microneedles enable painless transdermal delivery at micrometer scale.
How the study worked
Review of recent advances in peptide drug delivery focusing on oral and transdermal routes, with detailed discussion of aquasome nanoparticle design and microneedle technology types and mechanisms.
Who was studied
Protein and peptide drug delivery technologies across preclinical and early clinical stages
What this study cannot tell us
Review of technologies at various development stages — many not yet clinically validated. Scale-up manufacturing challenges for both aquasomes and microneedles. Regulatory pathways for novel delivery devices are complex.
How to read the evidence
Review of emerging delivery technologies at various development stages. Conceptual frameworks are well-supported but clinical validation data is limited.
When this study was published
Published in 2021. Both aquasome and microneedle technologies continue to advance toward clinical application.
The bigger picture
As the peptide drug pipeline grows (GLP-1 agonists, antimicrobial peptides, etc.), delivery technology becomes the critical bottleneck. Technologies like aquasomes and microneedles could dramatically expand patient access to peptide therapeutics.
Questions still open
- Can aquasomes achieve sufficient oral bioavailability for potent peptide drugs like insulin?
- Are microneedle patches practical for self-administration of peptide drugs at home?
- Which peptide drugs are best suited for each delivery platform?
Common questions
Why can't most peptide drugs be taken as pills?
Are microneedle patches painful?
Read the original research
Advanced trends in protein and peptide drug delivery: a special emphasis on aquasomes and microneedles techniques.
Drug delivery and translational research, 11(1), 1-23
Citation
Asfour, Marwa Hasanein. (2021). Advanced trends in protein and peptide drug delivery: a special emphasis on aquasomes and microneedles techniques.. Drug delivery and translational research, 11(1), 1-23. https://doi.org/10.1007/s13346-020-00746-z